The effect of near-infrared fluorescence conjugation on the anti-cancer potential of cetuximab / 한국실험동물학회지
Laboratory Animal Research
;
: 30-36, 2018.
Artículo
en Inglés
| WPRIM
| ID: wpr-713482
ABSTRACT
This study investigated the anti-cancer potential of a near-infrared fluorescence (NIRF) molecule conjugated with Cetuximab (Cetuximab-NIRF) in six-week-old female BALB/c athymic (nu+/nu+) nude mice. A431 cells were cultured and injected into the animals to induce solid tumors. Paclitaxel (30 mg/kg body weight (BW)), Cetuximab (1 mg/kg BW), and Cetuximab-NIRF (0.25, 0.5 and 1.0 mg/kg BW) were intraperitoneally injected twice a week into the A431 cell xenografts of the nude mice. Changes in BW, tumor volume and weight, fat and lean mass, and diameter of the peri-tumoral blood vessel were determined after two weeks. Tumor volumes and weights were significantly decreased in the Cetuximab-NIRF (1 mg/kg BW) group compared with the control group (P < 0.001). Lean mass and total body water content were also conspicuously reduced in the Cetuximab-NIRF (1 mg/kg BW) group compared with the vehicle control group. Peri-tumoral blood vessel diameters were very thin in the Cetuximab-NIRF groups compared with those of the paclitaxel group. These results indicate that the conjugation of Cetuximab with NIRF does not affect the anti-cancer potential of Cetuximab and NIRF can be used for molecular imaging in cancer treatments.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Pesos y Medidas
/
Vasos Sanguíneos
/
Agua Corporal
/
Peso Corporal
/
Paclitaxel
/
Carga Tumoral
/
Imagen Molecular
/
Xenoinjertos
/
Fluorescencia
/
Cetuximab
Límite:
Animales
/
Femenino
/
Humanos
Idioma:
Inglés
Revista:
Laboratory Animal Research
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS